Erica Schohn Email & Phone Number

My practice focuses on compensation and benefits arrangements in U.S. and cross-border corporate transactions (including mergers and acquisitions, public offerings and bankruptcy reorganizations), the negotiation of executive employment and severance arrangements, and the drafting and implementation of equity and other compensation programs.I frequently advise clients on the U.S. Securities and Exchange Commission (SEC) rules governing executive compensation disclosure and corporate governance matters relating to compensation practices. As part of this practice, I am a member of panels and committees comprised of leading government and private- and public-company governance professionals, and speak regularly with representatives from the SEC, stock exchanges, institutional investor groups and proxy advisory firms on the latest issues in corporate governance.I also regularly advise clients regarding tax planning with respect to compliance with Internal Revenue Code Section 409A and the tax rules relating to deferred compensation, the excise tax on excess parachute payments, and limits on the deductibility of executive compensation.My experience includes representing companies, private equity funds and individuals in, among others, the pharmaceutical, medical supply, financial, energy, entertainment and travel industries.I am the author and editor of the Section 409A Handbook, published by Bloomberg BNA, and speak at seminars on issues relating to executive compensation, tax planning and corporate governance. I am a member of the Skadden team that was recognized by Chambers USA in 2013 with its Award for Excellence, given annually to a select group of firms on the basis of pre-eminence in key practice areas.

Listed skills include Securities Regulation, Corporate Governance, Executive Pay, Corporate Transactional, and 3 others.

• 

  Partner, Executive Compensation And Benefits

  Skadden, Arps, Slate, Meagher & Flom Llp

  Sep 2003 - Present - Greater New York City Area

  My representations include:• Apax Partners LLP (United Kingdom) in the sale of a majority stake in Advantage Sales & Marketing LLC to affiliates of private equity firm Leonard Green & Partners, L.P. and funds advised by CVC Capital Partners Limited (United Kingdom);• Becton, Dickinson and Company in its $12.2 billion acquisition of CareFusion Corporation. Both companies are manufacturers of health care products;• Endo Health Solutions Inc. in its $1.6 billion acquisition of Paladin Labs Inc. and its relocation to Ireland;• Endo International plc (Ireland) in the $1.65 billion sale of American Medical Systems Holdings Inc.’s men’s and prostate health business to Boston Scientific Corporation;• JGWPT Holdings, Inc. (a portfolio company of JLL Partners), the holding company for J.G. Wentworth and Peachtree Financial Solutions, in its $137 million initial public offering of Class A common stock and listing on the New York Stock Exchange;• Medtronic in executive compensation matters related to its $50 billion merger with Covidien;• National Financial Partners Corp. in its $1.3 billion acquisition by Madison Dearborn Partners, LLC;• NPS Pharmaceuticals, Inc. in its $5.2 billion acquisition by Shire plc (Ireland);• Sensata Technologies Holding N.V. (the Netherlands) in the $1 billion acquisition by its wholly owned indirect subsidiary Sensata Technologies B.V. of Schrader International, Inc. from Madison Dearborn Partners;• Valeant Pharmaceuticals International, Inc. in its $8.7 billion acquisition of Bausch & Lomb Holdings Incorporated; and• Veritas Capital in the $381 million acquisition of Anaren, Inc. by an affiliate of The Veritas Capital Fund IV, L.P.I also have provided advisory work on compensation, benefits, securities and tax-related matters for public and private companies including, among others, Endo Health Solutions Inc.; Janus Capital Group; Medtronic Inc.; Realogy and Valeant Pharmaceuticals International, Inc.